nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—BCHE—Cisplatin—urinary bladder cancer	0.536	1	CbGbCtD
Terbutaline—Allergic cutaneous angiitis—Methotrexate—urinary bladder cancer	0.0138	0.0307	CcSEcCtD
Terbutaline—Injection site pain—Thiotepa—urinary bladder cancer	0.0125	0.0278	CcSEcCtD
Terbutaline—Clenbuterol—TNF—urinary bladder cancer	0.0114	0.704	CrCbGaD
Terbutaline—Drowsiness—Mitomycin—urinary bladder cancer	0.0113	0.0253	CcSEcCtD
Terbutaline—Chest pain—Valrubicin—urinary bladder cancer	0.0109	0.0244	CcSEcCtD
Terbutaline—Leukocytoclastic vasculitis—Methotrexate—urinary bladder cancer	0.00893	0.0199	CcSEcCtD
Terbutaline—Chest discomfort—Etoposide—urinary bladder cancer	0.00826	0.0184	CcSEcCtD
Terbutaline—Asthenia—Valrubicin—urinary bladder cancer	0.00752	0.0168	CcSEcCtD
Terbutaline—Dizziness—Valrubicin—urinary bladder cancer	0.00693	0.0155	CcSEcCtD
Terbutaline—Vomiting—Valrubicin—urinary bladder cancer	0.00666	0.0149	CcSEcCtD
Terbutaline—Rash—Valrubicin—urinary bladder cancer	0.00661	0.0148	CcSEcCtD
Terbutaline—Dermatitis—Valrubicin—urinary bladder cancer	0.0066	0.0147	CcSEcCtD
Terbutaline—Headache—Valrubicin—urinary bladder cancer	0.00657	0.0147	CcSEcCtD
Terbutaline—Dyspnoea—Mitomycin—urinary bladder cancer	0.00644	0.0144	CcSEcCtD
Terbutaline—Somnolence—Mitomycin—urinary bladder cancer	0.00642	0.0143	CcSEcCtD
Terbutaline—Nausea—Valrubicin—urinary bladder cancer	0.00623	0.0139	CcSEcCtD
Terbutaline—Cramp muscle—Cisplatin—urinary bladder cancer	0.00522	0.0116	CcSEcCtD
Terbutaline—Asthenia—Mitomycin—urinary bladder cancer	0.00518	0.0116	CcSEcCtD
Terbutaline—Hallucination—Thiotepa—urinary bladder cancer	0.00509	0.0114	CcSEcCtD
Terbutaline—Injection site pain—Epirubicin—urinary bladder cancer	0.00502	0.0112	CcSEcCtD
Terbutaline—Cramp muscle—Etoposide—urinary bladder cancer	0.00478	0.0107	CcSEcCtD
Terbutaline—Dizziness—Mitomycin—urinary bladder cancer	0.00477	0.0107	CcSEcCtD
Terbutaline—Epinephrine—TNF—urinary bladder cancer	0.00477	0.296	CrCbGaD
Terbutaline—Injection site pain—Doxorubicin—urinary bladder cancer	0.00464	0.0104	CcSEcCtD
Terbutaline—Sweating—Gemcitabine—urinary bladder cancer	0.00459	0.0103	CcSEcCtD
Terbutaline—Vomiting—Mitomycin—urinary bladder cancer	0.00459	0.0103	CcSEcCtD
Terbutaline—Rash—Mitomycin—urinary bladder cancer	0.00455	0.0102	CcSEcCtD
Terbutaline—Dermatitis—Mitomycin—urinary bladder cancer	0.00455	0.0102	CcSEcCtD
Terbutaline—Ventricular extrasystoles—Epirubicin—urinary bladder cancer	0.00454	0.0101	CcSEcCtD
Terbutaline—Headache—Mitomycin—urinary bladder cancer	0.00452	0.0101	CcSEcCtD
Terbutaline—Tension—Thiotepa—urinary bladder cancer	0.00437	0.00975	CcSEcCtD
Terbutaline—Nervousness—Thiotepa—urinary bladder cancer	0.00432	0.00965	CcSEcCtD
Terbutaline—Nausea—Mitomycin—urinary bladder cancer	0.00429	0.00958	CcSEcCtD
Terbutaline—Ventricular extrasystoles—Doxorubicin—urinary bladder cancer	0.0042	0.00937	CcSEcCtD
Terbutaline—Anxiety—Thiotepa—urinary bladder cancer	0.00377	0.00843	CcSEcCtD
Terbutaline—Flushing—Cisplatin—urinary bladder cancer	0.00372	0.0083	CcSEcCtD
Terbutaline—Hypertonia—Epirubicin—urinary bladder cancer	0.00359	0.00802	CcSEcCtD
Terbutaline—Tachycardia—Thiotepa—urinary bladder cancer	0.00354	0.00791	CcSEcCtD
Terbutaline—Flushing—Etoposide—urinary bladder cancer	0.00341	0.00761	CcSEcCtD
Terbutaline—Muscle spasms—Cisplatin—urinary bladder cancer	0.00335	0.00749	CcSEcCtD
Terbutaline—Hypertonia—Doxorubicin—urinary bladder cancer	0.00332	0.00742	CcSEcCtD
Terbutaline—Tremor—Cisplatin—urinary bladder cancer	0.00327	0.0073	CcSEcCtD
Terbutaline—Paraesthesia—Thiotepa—urinary bladder cancer	0.00326	0.00728	CcSEcCtD
Terbutaline—Somnolence—Thiotepa—urinary bladder cancer	0.00323	0.00721	CcSEcCtD
Terbutaline—Chest pain—Gemcitabine—urinary bladder cancer	0.00319	0.00711	CcSEcCtD
Terbutaline—Chest pain—Fluorouracil—urinary bladder cancer	0.00313	0.007	CcSEcCtD
Terbutaline—Muscle spasms—Etoposide—urinary bladder cancer	0.00307	0.00686	CcSEcCtD
Terbutaline—Anxiety—Cisplatin—urinary bladder cancer	0.00296	0.00661	CcSEcCtD
Terbutaline—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00295	0.00659	CcSEcCtD
Terbutaline—Tachycardia—Fluorouracil—urinary bladder cancer	0.00293	0.00654	CcSEcCtD
Terbutaline—Tachycardia—Cisplatin—urinary bladder cancer	0.00278	0.0062	CcSEcCtD
Terbutaline—Insomnia—Gemcitabine—urinary bladder cancer	0.00276	0.00617	CcSEcCtD
Terbutaline—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00275	0.00615	CcSEcCtD
Terbutaline—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00274	0.00612	CcSEcCtD
Terbutaline—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00272	0.00608	CcSEcCtD
Terbutaline—Chest pain—Etoposide—urinary bladder cancer	0.00272	0.00608	CcSEcCtD
Terbutaline—Insomnia—Fluorouracil—urinary bladder cancer	0.00272	0.00607	CcSEcCtD
Terbutaline—Somnolence—Gemcitabine—urinary bladder cancer	0.00272	0.00606	CcSEcCtD
Terbutaline—Paraesthesia—Fluorouracil—urinary bladder cancer	0.0027	0.00602	CcSEcCtD
Terbutaline—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00268	0.00598	CcSEcCtD
Terbutaline—Somnolence—Fluorouracil—urinary bladder cancer	0.00267	0.00596	CcSEcCtD
Terbutaline—Asthenia—Thiotepa—urinary bladder cancer	0.00261	0.00582	CcSEcCtD
Terbutaline—Paraesthesia—Cisplatin—urinary bladder cancer	0.00256	0.00571	CcSEcCtD
Terbutaline—Tachycardia—Etoposide—urinary bladder cancer	0.00255	0.00568	CcSEcCtD
Terbutaline—Dyspnoea—Cisplatin—urinary bladder cancer	0.00254	0.00567	CcSEcCtD
Terbutaline—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00252	0.00563	CcSEcCtD
Terbutaline—Drowsiness—Methotrexate—urinary bladder cancer	0.00245	0.00547	CcSEcCtD
Terbutaline—Dizziness—Thiotepa—urinary bladder cancer	0.0024	0.00536	CcSEcCtD
Terbutaline—Sweating—Methotrexate—urinary bladder cancer	0.00235	0.00524	CcSEcCtD
Terbutaline—Paraesthesia—Etoposide—urinary bladder cancer	0.00234	0.00523	CcSEcCtD
Terbutaline—Dyspnoea—Etoposide—urinary bladder cancer	0.00233	0.00519	CcSEcCtD
Terbutaline—Somnolence—Etoposide—urinary bladder cancer	0.00232	0.00518	CcSEcCtD
Terbutaline—Vomiting—Thiotepa—urinary bladder cancer	0.00231	0.00516	CcSEcCtD
Terbutaline—Drowsiness—Epirubicin—urinary bladder cancer	0.00229	0.00512	CcSEcCtD
Terbutaline—Rash—Thiotepa—urinary bladder cancer	0.00229	0.00511	CcSEcCtD
Terbutaline—Dermatitis—Thiotepa—urinary bladder cancer	0.00229	0.00511	CcSEcCtD
Terbutaline—Headache—Thiotepa—urinary bladder cancer	0.00227	0.00508	CcSEcCtD
Terbutaline—Sweating—Epirubicin—urinary bladder cancer	0.0022	0.00491	CcSEcCtD
Terbutaline—Asthenia—Gemcitabine—urinary bladder cancer	0.00219	0.00489	CcSEcCtD
Terbutaline—Nausea—Thiotepa—urinary bladder cancer	0.00216	0.00482	CcSEcCtD
Terbutaline—Drowsiness—Doxorubicin—urinary bladder cancer	0.00212	0.00474	CcSEcCtD
Terbutaline—Asthenia—Cisplatin—urinary bladder cancer	0.00204	0.00456	CcSEcCtD
Terbutaline—Sweating—Doxorubicin—urinary bladder cancer	0.00203	0.00454	CcSEcCtD
Terbutaline—Dizziness—Fluorouracil—urinary bladder cancer	0.00199	0.00443	CcSEcCtD
Terbutaline—Vomiting—Gemcitabine—urinary bladder cancer	0.00194	0.00434	CcSEcCtD
Terbutaline—Rash—Gemcitabine—urinary bladder cancer	0.00193	0.0043	CcSEcCtD
Terbutaline—Dermatitis—Gemcitabine—urinary bladder cancer	0.00192	0.0043	CcSEcCtD
Terbutaline—Headache—Gemcitabine—urinary bladder cancer	0.00191	0.00427	CcSEcCtD
Terbutaline—Flushing—Epirubicin—urinary bladder cancer	0.00191	0.00426	CcSEcCtD
Terbutaline—Vomiting—Fluorouracil—urinary bladder cancer	0.00191	0.00426	CcSEcCtD
Terbutaline—Rash—Fluorouracil—urinary bladder cancer	0.00189	0.00423	CcSEcCtD
Terbutaline—Dermatitis—Fluorouracil—urinary bladder cancer	0.00189	0.00422	CcSEcCtD
Terbutaline—Headache—Fluorouracil—urinary bladder cancer	0.00188	0.0042	CcSEcCtD
Terbutaline—Asthenia—Etoposide—urinary bladder cancer	0.00187	0.00418	CcSEcCtD
Terbutaline—Nausea—Gemcitabine—urinary bladder cancer	0.00181	0.00405	CcSEcCtD
Terbutaline—Vomiting—Cisplatin—urinary bladder cancer	0.00181	0.00404	CcSEcCtD
Terbutaline—Rash—Cisplatin—urinary bladder cancer	0.0018	0.00401	CcSEcCtD
Terbutaline—Dermatitis—Cisplatin—urinary bladder cancer	0.00179	0.004	CcSEcCtD
Terbutaline—Nausea—Fluorouracil—urinary bladder cancer	0.00178	0.00398	CcSEcCtD
Terbutaline—Flushing—Doxorubicin—urinary bladder cancer	0.00177	0.00395	CcSEcCtD
Terbutaline—Tension—Epirubicin—urinary bladder cancer	0.00176	0.00393	CcSEcCtD
Terbutaline—Nervousness—Epirubicin—urinary bladder cancer	0.00174	0.00389	CcSEcCtD
Terbutaline—Dizziness—Etoposide—urinary bladder cancer	0.00172	0.00385	CcSEcCtD
Terbutaline—Muscle spasms—Epirubicin—urinary bladder cancer	0.00172	0.00385	CcSEcCtD
Terbutaline—Nausea—Cisplatin—urinary bladder cancer	0.00169	0.00378	CcSEcCtD
Terbutaline—Vomiting—Etoposide—urinary bladder cancer	0.00166	0.0037	CcSEcCtD
Terbutaline—Rash—Etoposide—urinary bladder cancer	0.00164	0.00367	CcSEcCtD
Terbutaline—Dermatitis—Etoposide—urinary bladder cancer	0.00164	0.00367	CcSEcCtD
Terbutaline—Headache—Etoposide—urinary bladder cancer	0.00163	0.00365	CcSEcCtD
Terbutaline—Chest pain—Methotrexate—urinary bladder cancer	0.00163	0.00364	CcSEcCtD
Terbutaline—Tension—Doxorubicin—urinary bladder cancer	0.00163	0.00363	CcSEcCtD
Terbutaline—Nervousness—Doxorubicin—urinary bladder cancer	0.00161	0.00359	CcSEcCtD
Terbutaline—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00159	0.00356	CcSEcCtD
Terbutaline—Palpitations—Epirubicin—urinary bladder cancer	0.00158	0.00354	CcSEcCtD
Terbutaline—Nausea—Etoposide—urinary bladder cancer	0.00155	0.00346	CcSEcCtD
Terbutaline—Chest pain—Epirubicin—urinary bladder cancer	0.00153	0.00341	CcSEcCtD
Terbutaline—Anxiety—Epirubicin—urinary bladder cancer	0.00152	0.00339	CcSEcCtD
Terbutaline—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00151	0.00337	CcSEcCtD
Terbutaline—Dry mouth—Epirubicin—urinary bladder cancer	0.00149	0.00333	CcSEcCtD
Terbutaline—Palpitations—Doxorubicin—urinary bladder cancer	0.00146	0.00327	CcSEcCtD
Terbutaline—Tachycardia—Epirubicin—urinary bladder cancer	0.00143	0.00319	CcSEcCtD
Terbutaline—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00141	0.00316	CcSEcCtD
Terbutaline—Insomnia—Methotrexate—urinary bladder cancer	0.00141	0.00316	CcSEcCtD
Terbutaline—Chest pain—Doxorubicin—urinary bladder cancer	0.00141	0.00315	CcSEcCtD
Terbutaline—Anxiety—Doxorubicin—urinary bladder cancer	0.00141	0.00314	CcSEcCtD
Terbutaline—Paraesthesia—Methotrexate—urinary bladder cancer	0.0014	0.00313	CcSEcCtD
Terbutaline—Dyspnoea—Methotrexate—urinary bladder cancer	0.00139	0.00311	CcSEcCtD
Terbutaline—Somnolence—Methotrexate—urinary bladder cancer	0.00139	0.0031	CcSEcCtD
Terbutaline—Dry mouth—Doxorubicin—urinary bladder cancer	0.00138	0.00308	CcSEcCtD
Terbutaline—Insomnia—Epirubicin—urinary bladder cancer	0.00132	0.00295	CcSEcCtD
Terbutaline—Tachycardia—Doxorubicin—urinary bladder cancer	0.00132	0.00295	CcSEcCtD
Terbutaline—Paraesthesia—Epirubicin—urinary bladder cancer	0.00131	0.00293	CcSEcCtD
Terbutaline—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00131	0.00292	CcSEcCtD
Terbutaline—Dyspnoea—Epirubicin—urinary bladder cancer	0.0013	0.00291	CcSEcCtD
Terbutaline—Somnolence—Epirubicin—urinary bladder cancer	0.0013	0.0029	CcSEcCtD
Terbutaline—Insomnia—Doxorubicin—urinary bladder cancer	0.00122	0.00273	CcSEcCtD
Terbutaline—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00121	0.00271	CcSEcCtD
Terbutaline—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00121	0.00269	CcSEcCtD
Terbutaline—Somnolence—Doxorubicin—urinary bladder cancer	0.0012	0.00269	CcSEcCtD
Terbutaline—Asthenia—Methotrexate—urinary bladder cancer	0.00112	0.0025	CcSEcCtD
Terbutaline—Asthenia—Epirubicin—urinary bladder cancer	0.00105	0.00234	CcSEcCtD
Terbutaline—Dizziness—Methotrexate—urinary bladder cancer	0.00103	0.00231	CcSEcCtD
Terbutaline—Vomiting—Methotrexate—urinary bladder cancer	0.000993	0.00222	CcSEcCtD
Terbutaline—Rash—Methotrexate—urinary bladder cancer	0.000985	0.0022	CcSEcCtD
Terbutaline—Dermatitis—Methotrexate—urinary bladder cancer	0.000984	0.0022	CcSEcCtD
Terbutaline—Headache—Methotrexate—urinary bladder cancer	0.000979	0.00219	CcSEcCtD
Terbutaline—Asthenia—Doxorubicin—urinary bladder cancer	0.000971	0.00217	CcSEcCtD
Terbutaline—Dizziness—Epirubicin—urinary bladder cancer	0.000967	0.00216	CcSEcCtD
Terbutaline—Vomiting—Epirubicin—urinary bladder cancer	0.00093	0.00208	CcSEcCtD
Terbutaline—Nausea—Methotrexate—urinary bladder cancer	0.000928	0.00207	CcSEcCtD
Terbutaline—Rash—Epirubicin—urinary bladder cancer	0.000922	0.00206	CcSEcCtD
Terbutaline—Dermatitis—Epirubicin—urinary bladder cancer	0.000921	0.00206	CcSEcCtD
Terbutaline—Headache—Epirubicin—urinary bladder cancer	0.000916	0.00205	CcSEcCtD
Terbutaline—Dizziness—Doxorubicin—urinary bladder cancer	0.000895	0.002	CcSEcCtD
Terbutaline—Nausea—Epirubicin—urinary bladder cancer	0.000868	0.00194	CcSEcCtD
Terbutaline—Vomiting—Doxorubicin—urinary bladder cancer	0.00086	0.00192	CcSEcCtD
Terbutaline—Rash—Doxorubicin—urinary bladder cancer	0.000853	0.0019	CcSEcCtD
Terbutaline—Dermatitis—Doxorubicin—urinary bladder cancer	0.000852	0.0019	CcSEcCtD
Terbutaline—Headache—Doxorubicin—urinary bladder cancer	0.000848	0.00189	CcSEcCtD
Terbutaline—Nausea—Doxorubicin—urinary bladder cancer	0.000804	0.00179	CcSEcCtD
